From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area
From the American Epicenter: Coronavirus Disease 2019 in Patients with Inflammatory Bowel Disease in the New York City Metropolitan Area
复制标题
DOI：
10.1093/ibd/izaa162
复制
发表时间：
2021-05-01
影响因子：
4.9
通讯作者：
Hudesman, David
中科院分区：
文献类型：
--
作者：
Axelrad, Jordan E.;Malter, Lisa;Hudesman, David
背景：我们旨在了解炎症性肠病和新型冠状病毒病2019(新冠肺炎)患者的特征。方法：我们对确诊或高度怀疑新冠肺炎的炎症性肠病患者进行了一系列病例系列研究，以评估严重转归的比率。结果：我们确定83例炎症性肠病患者确诊为新冠肺炎或高度怀疑新冠肺炎。总体住院率为6%，通常包括活动期克罗恩病患者或合并疾病的老年男性，1名患者已出院。讨论：在这一系列IBD患者中，新冠肺炎的严重后果是罕见的，与普通人群中类似年龄的个体相当。
Background: We aimed to characterize patients with inflammatory bowel disease (IBD) and novel coronavirus disease 2019 (COVID-19).Methods: We performed a case series of patients with IBD and confirmed or highly suspected COVID-19 to assess rates of severe outcomes.Results: We identified 83 patients with IBD with confirmed (54%) or highly suspected (46%) COVID-19. The overall hospitalization rate was 6%, generally comprising patients with active Crohn's disease or older men with comorbidities, and 1 patient expired.Discussion: In this series of patients with IBD, severe outcomes of COVID-19 were rare and comparable to similarly aged individuals in the general population.